Orexo AB (publ) C5G.F Stock
Orexo AB (publ) Price Chart
Orexo AB (publ) C5G.F Financial and Trading Overview
| Orexo AB (publ) stock price | 1.89 EUR |
| Previous Close | 0.76 EUR |
| Open | 0.76 EUR |
| Bid | 0.77 EUR x 0 |
| Ask | 0.85 EUR x 0 |
| Day's Range | 0.76 - 0.76 EUR |
| 52 Week Range | 0.74 - 3.17 EUR |
| Volume | 1K EUR |
| Avg. Volume | 18 EUR |
| Market Cap | 26.97M EUR |
| Beta (5Y Monthly) | 0.605747 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.19 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
C5G.F Valuation Measures
| Enterprise Value | 26.19M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.55209845 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Orexo AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.605747 |
| 52-Week Change | -58.58% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.17 EUR |
| 52 Week Low | 0.74 EUR |
| 50-Day Moving Average | 1.02 EUR |
| 200-Day Moving Average | 1.52 EUR |
C5G.F Share Statistics
| Avg. Volume (3 month) | 18 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 34.37M |
| Float | 21.62M |
| Short Ratio | N/A |
| % Held by Insiders | 17.29% |
| % Held by Institutions | 41.24% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -34.93% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 83.35% |
| EBITDA Margin | -18.80% |
Management Effectiveness
| Return on Assets (ttm) | -9.25% |
| Return on Equity (ttm) | -95.028% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | -0.40% |
| Gross Profit (ttm) | 521.7M EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.54 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 410.84 EUR |
| Current Ratio (mrq) | 1.928 |
| Book Value Per Share (mrq) | 1.382 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Orexo AB (publ)
| Country | Germany |
| State | N/A |
| City | Uppsala |
| Address | Rapsgatan 7E |
| ZIP | N/A |
| Phone | 46 1 87 80 88 00 |
| Website | https://www.orexo.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 122 |
Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is also developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.
Q&A For Orexo AB (publ) Stock
What is a current C5G.F stock price?
Orexo AB (publ) C5G.F stock price today per share is 1.89 EUR.
How to purchase Orexo AB (publ) stock?
You can buy C5G.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Orexo AB (publ)?
The stock symbol or ticker of Orexo AB (publ) is C5G.F.
Which industry does the Orexo AB (publ) company belong to?
The Orexo AB (publ) industry is Drug Manufacturers-Specialty & Generic.
How many shares does Orexo AB (publ) have in circulation?
The max supply of Orexo AB (publ) shares is 34.45M.
What is Orexo AB (publ) Price to Earnings Ratio (PE Ratio)?
Orexo AB (publ) PE Ratio is now.
What was Orexo AB (publ) earnings per share over the trailing 12 months (TTM)?
Orexo AB (publ) EPS is -0.19 EUR over the trailing 12 months.
Which sector does the Orexo AB (publ) company belong to?
The Orexo AB (publ) sector is Healthcare.